Medical Devices Startups

PCaVision combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering a diagnostic pathway for urologists that avoids the need for MRI. It targets clinics, hospitals, and urologists, and is CE/MDR Class IIb certified for use in authorized EU markets.

1 investor

PCI Biotech develops bioprocessing technologies for manufacturing viral vectors and intracellular drug delivery solutions, serving immunotherapy and dermatology applications.

1 investor

Precision Cardiovascular develops implantable cardiac monitoring devices for heart failure patients, focusing on exercise and stress monitoring gaps in current clinical systems. The company is advancing next-generation sensor technology through regulatory review and clinical evaluation processes.

1 investor

Peak Medical develops AI-powered healthcare technology designed to improve diagnostic and treatment accessibility in underserved populations. The company focuses on affordable, sensor-free solutions that address health equity and reduce barriers to care regardless of geographic location or financial constraints.

1 investor

Pedasys designs and manufactures robotic exoskeleton systems for mobility assistance and rehabilitation, serving paraplegic patients, elderly individuals, people with disabilities, athletes, and workers performing repetitive tasks. The company produces Exopod, an exoskeleton device that has received Iranian Ministry of Health approval and ISO 13485 certification.

1 investor

Peds3 develops digital and evidence-based care solutions for pediatric and maternal-child health, serving healthcare providers and families through treatment applications and medical programs. The company applies AI and digital technology alongside scientific research to implement comprehensive biopsychosocial care in clinical practice across Japan.

1 investor

Peerbridge Health develops solutions focused on cardiac care and clinical insight.

1 investor

Pelton Shepherd provides cold chain packaging solutions and refrigerant expertise to customers requiring temperature-controlled supply logistics. The company operates as a third-generation family business with over 70 years of industry experience.

1 investor

Penn Health Group is a Pennsylvania-based medical cannabis provider that offers a range of approved cannabis products in various forms including flower, oils, liquids, capsules, tinctures, and topicals for patients seeking therapeutic relief.

1 investor

Penta Medical makes hardware devices for managing athletic injuries, used by sports teams and medical professionals to monitor athlete health and customize recovery protocols.

1 investor

Penta is a nonprofit social venture that collects used and surplus prosthetic equipment from the United States and distributes it to amputees in low- and middle-income countries. The organization operates across 16 countries globally to restore physical, social, and economic mobility for people lacking access to affordable prosthetic care.

1 investor

Pentec Health is a national provider of clinical nutrition and specialty care services, integrating pharmacy services with clinical expertise for patients with complex conditions including dialysis, wound care, metabolic disorders, and oncology needs. The company delivers home-based and clinical infusion therapies, compounded medications, and nutritional support to over 12,500 patients through a team of 350+ clinicians.

1 investor

LEO Pharma is a global pharmaceutical company specializing in medical dermatology treatments for skin diseases, with additional focus on critical care including thrombosis and immunooncology. The company serves over 100 million patients annually across 70+ countries and employs 4,000 people.

1 investor

Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.

1 investor

Perception Medicine develops AI-driven precision oncology solutions for cancer patients. The company's team combines expertise in artificial intelligence, clinical medicine, and product design, with roots in Stanford and MIT research.

1 investor

Percy provides data-driven sleep diagnostics and behavioral sleep therapy tools for healthcare providers treating sleep disorders, particularly for neurodivergent populations and people with chronic medical conditions.

1 investor

Performance Health manufactures and distributes rehabilitation, physical therapy, sports medicine, and wellness products and services for healthcare providers and consumers. The company operates as North America's largest rehabilitation supplier with over 70 years of expertise in the rehabilitation market.

1 investor

PeriGen develops software technology that identifies potential complications during childbirth to help clinicians around the world prevent avoidable harm during labor and delivery. The company serves healthcare providers and perinatal care teams globally.

1 investor

Perigon Health provides a digital health platform that integrates medication dispensing devices, physiological monitoring, and reimbursement systems to track patient adherence and improve medication outcomes. The platform connects health APIs and serves healthcare providers and pharmacies seeking enhanced patient insight and reimbursement efficiency.

1 investor

Perimeter Medical Imaging AI develops ultra-high resolution imaging tools and AI software to help surgeons assess tumor margins during cancer surgery in real-time. The Toronto-based company aims to reduce the need for repeat surgeries by enabling surgeons to detect remaining cancer cells using proprietary Optical Coherence Tomography technology.

1 investor

Periomedic develops medical visualization systems and provides contract development and manufacturing (CDMO) services in the medical device sector. The company focuses on commercializing complex visualization products for the medical market.

1 investor

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.

1 investor

P-Scope manufactures a disposable minimally invasive scope for direct abdominal cavity visualization under local anesthesia, designed for gastroenterology, oncology, gynecology, and critical care applications. The device eliminates the need for general anesthesia and inpatient surgery for diagnostic abdominal examination.

1 investor

Perlara is a biopharmaceutical company that develops treatments for ultra-rare genetic diseases using yeast-based disease modeling and drug repurposing strategies. The company operates as a full-stack drug development platform serving rare disease patients and families.

1 investor